PrymaLab Publishes Safety Data Sheets for All Research Compounds

PrymaLab, a veteran-owned research peptide supplier based in Ashland, Kentucky, has taken a significant step in enhancing safety and transparency for its customers by publishing safety data sheets (SDS) for every research compound it supplies. As of October 3, 2026, the company has issued 189 SDS sheets, covering 97 compounds and blends, with 33 of these sheets carrying a Globally Harmonized System (GHS) hazard classification.

The SDS sheets are available at prymalab.net/testing/sds, providing a comprehensive resource for researchers and laboratory safety officers. Each sheet follows the 16-section structure required by the Occupational Safety and Health Administration (OSHA) Hazard Communication Standard, covering identification, hazard identification, handling and storage, exposure controls, stability, toxicology, and disposal. Document numbers range from PL-SDS-001 to PL-SDS-189, all dated October 3, 2026, at revision 1.0.

For compounds that are not classified as hazardous, the practical content is found in sections 7, 8, 10, and 13, detailing storage, protection during handling, incompatibilities, and disposal methods. For classified compounds, section 2 includes the signal word, pictograms, and hazard statements, while section 11 outlines the toxicological basis for these classifications.

PrymaLab's approach to classification is meticulous. For research peptides and novel small molecules, the company primarily references the safety data sheets published by Cayman Chemical for the same compounds. Where a pharmaceutical manufacturer's sheet or a notified European classification is more conservative and internally consistent, those are adopted instead. For commodity materials such as vitamins, amino acids, and excipients, PrymaLab references Sigma-Aldrich and Merck sheets. In cases where no supplier sheet exists, the company self-classifies by read-across from the closest well-characterized analogue and clearly states this on the sheet. Acute toxicity figures are quoted only where a supplier sheet provides them.

The company's reasoning for this initiative is clear: a safety data sheet is the document a laboratory safety officer asks for before a new material is allowed on the bench. PrymaLab believes that the sheet should be one click away for every item it supplies, whether or not anyone has asked. This move addresses a common gap in the research community, where researchers typically receive only a label, a purity figure, and nothing about hazard classification, handling, spill response, or disposal.

PrymaLab's customers often ask about storage conditions, and the SDS sheets now provide this information in a form that can be printed and kept with the material. Section 7 of the lyophilized-powder sheets gives the storage temperature for the sealed vial, the acceptable short-term range, and the requirement to keep the material desiccated and protected from light. Section 10 covers stability and the conditions to avoid. These sheets are now published in three places: the full sheet and a PDF sit in the Additional information tab of the relevant product page, below the lot certificate of analysis, across PrymaLab's research peptide pages. An index at prymalab.net/testing/sds lists every sheet by compound, with its hazard status and links to read or download. Researchers can also reach the compound's safety data sheet from the same page, alongside the company's other laboratory references, including its Research Hub and its free peptide calculator.

PrymaLab plans a first revision cycle in early 2027, to incorporate new hazard data and customer corrections. The company intends to supply the sheets in the documentation pack that accompanies its partner and white-label shipments. This move is expected to enhance safety and compliance in research laboratories, providing a valuable resource for handling and managing research compounds.

In summary, PrymaLab's comprehensive safety data sheet initiative marks a significant step in improving safety and transparency in the research peptide supply chain.